BioInvent International (Sweden) Today
| BINV Stock | SEK 24.45 0.15 0.61% |
PerformanceVery Weak
| Odds Of DistressLow
|
BioInvent International is selling for under 24.45 as of the 26th of February 2025; that is 0.61 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 23.9. BioInvent International has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 28th of November 2024 and ending today, the 26th of February 2025. Click here to learn more.
BioInvent International AB focuses on the research and development of immunomodulating antibodies for the treatment of cancer in Sweden, Europe, and internationally. The Company was founded in 1997 and is based in Lund, Sweden. BioInvent International operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. The company has 65.8 M outstanding shares. More on BioInvent International AB
Moving together with BioInvent Stock
Moving against BioInvent Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BioInvent Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. BioInvent International's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BioInvent International or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO | Martin Welschof |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
BioInvent International AB (BINV) is traded on Stockholm Exchange in Sweden and employs 93 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.99 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioInvent International's market, we take the total number of its shares issued and multiply it by BioInvent International's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioInvent International operates under Biotechnology sector and is part of Health Care industry. The entity has 65.8 M outstanding shares.
BioInvent International AB has accumulated about 28.46 M in cash with (245.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
Check BioInvent International Probability Of Bankruptcy
Ownership AllocationBioInvent International holds a total of 65.8 Million outstanding shares. Over half of BioInvent International's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in BioInvent International. Please watch out for any change in the institutional holdings of BioInvent International as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BioInvent Ownership Details
BioInvent International Risk Profiles
Although BioInvent International's alpha and beta are two of the key measurements used to evaluate BioInvent International's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.11 | |||
| Standard Deviation | 2.91 | |||
| Variance | 8.46 | |||
| Risk Adjusted Performance | (0.23) |
BioInvent Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioInvent International without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
| All Next | Launch Module |
BioInvent International Corporate Management
Elected by the shareholders, the BioInvent International's board of directors comprises two types of representatives: BioInvent International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioInvent. The board's role is to monitor BioInvent International's management team and ensure that shareholders' interests are well served. BioInvent International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioInvent International's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andres McAllister | Chief Medical Officer | Profile | |
| Stefan MBA | Chief Officer | Profile | |
| Ingrid Teige | Head Research | Profile | |
| RGN MSc | Chief Officer | Profile | |
| Cecilia Hofvander | Director Relations | Profile |
Additional Tools for BioInvent Stock Analysis
When running BioInvent International's price analysis, check to measure BioInvent International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioInvent International is operating at the current time. Most of BioInvent International's value examination focuses on studying past and present price action to predict the probability of BioInvent International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioInvent International's price. Additionally, you may evaluate how the addition of BioInvent International to your portfolios can decrease your overall portfolio volatility.